𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is the clinical Queensland High Risk Foot Form valid or reliable for research?

✍ Scribed by Peter A Lazzarini, Vanessa Ng, Ewan M Kinnear…

Book ID
120698813
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
65 KB
Volume
6
Category
Article
ISSN
1757-1146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DNA-methylation of the homeodomain trans
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
✍ Sabine Maier; Inko Nimmrich; Thomas Koenig; Serenella Eppenberger-Castori; Inga 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 621 KB
ANNOUNCEMENTS: 4th Annual Meeting of the
ANNOUNCEMENTS: 4th Annual Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) The Marriott, Irvine, CA, USA 28–31 January 1999, Keystone Symposia Ocular Cell & Molecular Biology (OCMB) Announces Dean Bok, Ph.D. as the winner of the first OCMB Prize, Keystone OCMB Symposium, 1999 Keystone Colorado 5–10 February 1999, Call for Abstracts and Registration Organizers: Steven E. Wilson and Joe Hollyfield Registration and Abstract Forms available from: Keystone Symposia on Molecular and Cellular Biology Drawer 1630 Silverthorn, Colorado 80498 Telephone: 800-253-0685 Fax: 970-262-1525 E-mail: [email protected], XIV International Congress of Eye Research Santa Fe, New Mexico 15–20 October 2000, XV International Congress of Eye Research (2002) Proposals for the International Congress of Eye Research meeting to be held in the year 2002 are now being accepted by the ISER Council. The Jules François Prize of the Belgian Ophthalmological Societies 2000 The aim of the Jules François Prize is to encourage scientific research in ophthalmology. The prize of 10.000 U.S. Dollars will be awarded to a young scientist who has made an important contribution to ophthalmology. Eligibility: All topics in the field of fundamental and/or clinical research in ophthalmology will be considered. The application should be sent jointly with a curriculum vitae, the list of all publications and 3 copies of the candidates' 10 most relevant publications. The candidate should not be older than 40 years by 31 December 1999. Mailing Address: Jules François Foundation Secretary Prof. Dr. M. Hanssens Dienst Oogheelkunde De Pintelaan 185 B-9000 Gent, Belgium
📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 235 KB